Despite being the seventh adalimumab biosimilar approved in the United States, there are none on the market yet. The FDA has approved a seventh adalimumab biosimilar, Yusimry, which is developed by ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved the seventh biosimilar to adalimumab, adalimumab-aqvh, for all eligible indications of the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback